Acute ST-Segment Elevation Myocardial Infarction as Initial Presentation of Atypical Hemolytic-Uremic Syndrome.

ADAMTS13, ADAM metallopeptidase with thrombospondin type 1 motif 13 COVID-19, coronavirus disease-2019 CRRT, continuous renal replacement therapy HIT, heparin-induced thrombocytopenia LV, left ventricular STEMI, ST-segment elevation myocardial infarction aHUS, atypical hemolytic uremic syndrome acute heart failure autoimmune cardiovascular disease myocardial infarction

Journal

JACC. Case reports
ISSN: 2666-0849
Titre abrégé: JACC Case Rep
Pays: Netherlands
ID NLM: 101757292

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 22 06 2020
revised: 04 11 2020
accepted: 22 12 2020
entrez: 28 7 2021
pubmed: 29 7 2021
medline: 29 7 2021
Statut: epublish

Résumé

A young woman presented with an acute ST-segment elevation myocardial infarction. Her clinical course was complicated by cardiogenic shock and acute renal failure. Work-up revealed thrombocytopenia and hemolytic anemia. A diagnosis of atypical hemolytic-uremic syndrome was made on the basis of clinical and pathological findings. (

Identifiants

pubmed: 34317581
doi: 10.1016/j.jaccas.2020.12.033
pii: S2666-0849(21)00021-8
pmc: PMC8302770
doi:

Types de publication

Case Reports

Langues

eng

Pagination

561-565

Informations de copyright

© 2021 The Authors.

Déclaration de conflit d'intérêts

The authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Références

Nat Rev Nephrol. 2014 Mar;10(3):174-80
pubmed: 24419569
J Investig Med High Impact Case Rep. 2019 Jan-Dec;7:2324709619842905
pubmed: 31010328
Blood. 2017 May 25;129(21):2847-2856
pubmed: 28416508
JACC Cardiovasc Interv. 2017 Dec 26;10(24):2473-2487
pubmed: 29268880
N Engl J Med. 2009 Oct 22;361(17):1676-87
pubmed: 19846853
N Engl J Med. 2013 Jun 6;368(23):2169-81
pubmed: 23738544
Pediatr Nephrol. 2018 Aug;33(8):1395-1403
pubmed: 29610995

Auteurs

Edward Chau (E)

Department of Cardiovascular Disease, University of Southern California, Los Angeles, California, USA.

Shiqian Li (S)

Department of Pulmonary and Critical Care Medicine, University of Southern California, Los Angeles, California, USA.

Peter Z Xu (PZ)

Department of Cardiovascular Disease, University of Southern California, Los Angeles, California, USA.

Grace X Li (GX)

Department of Hematology, University of Southern California, Los Angeles, California, USA.

Wesley Ghasem (W)

Department of Cardiovascular Disease, University of Southern California, Los Angeles, California, USA.

Ilene C Weitz (IC)

Department of Hematology, University of Southern California, Los Angeles, California, USA.

Brittney K DeClerck (BK)

Department of Dermatology, University of Southern California, Los Angeles, California, USA.

Eugene C DePasquale (EC)

Department of Cardiovascular Disease, University of Southern California, Los Angeles, California, USA.

Bassam Yaghmour (B)

Department of Pulmonary and Critical Care Medicine, University of Southern California, Los Angeles, California, USA.

Classifications MeSH